- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
COVID-19
The Rheumatology Network COVID-19 clinical focus page provides information on the latest COVID-19 news, study and clinical trial findings, and clinical guideline updates for the treatment of COVID-19. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for COVID-19 drugs.
Amy Mudano, MPH: Increasing COVID-19 Vaccine Uptake in Patients with Rheumatic Disease
November 24, 2022
“These are people with autoimmune conditions who are taking immunomodulatory drugs that affect their immune system,” Mudano emphasized. “It's been shown that they may have worse outcomes if they do get COVID. So, it's important that they know that they really need this vaccine.”
Concomitant Methotrexate Linked to Reduced Efficacy of COVID-19 Booster Dose in Elderly Patients with RA
October 17, 2022
Recent findings suggest that methotrexate reduces humoral vaccination response against COVID-19 in older, but not younger, patients with rheumatoid arthritis.
Methotrexate Break Prevents Impairment of Variant Neutralization After COVID-19 Booster Dose
October 12, 2022
The neutralizing serum activity against variants in patients receiving methotrexate only increased 20-23-fold after booster vaccination, while the serum activity in those in the non-immunosuppressed group increased 67-73-fold.
Mycophenolic Acid Treatment Not Associated with More Severe COVID-19 Infection
September 28, 2022
Throughout the pandemic, rheumatologists have been concerned that their patients may be at risk of developing more severe forms of the COVID-19 disease as a result of their rheumatic disease or treatment.
COVID-19 Booster Improves Humoral, Cellular Immunogenicity in SLE, RA
July 29, 2022
Although a third dose of mRNA vaccine significantly increased antireceptor-binding domain (RBD) titer in a previous study, clinical factors associated with the immunogenicity in immunosuppressed populations have not been adequately studied.
COVID-19 Negatively Impacted Emotional and Social Wellbeing in Patients with RA
July 28, 2022
The top 5 themes identified surrounded fear as the dominant emotion, social connections and work, physical health, self-identity, and self-management as a way of coping.
Obesity Increases Risk of COVID-19 Hospitalization in Juvenile Patients
July 21, 2022
“Understanding the impact of COVID-19 infection on children and young people with RMDs is important to inform national protection, education (such as school attendance), and vaccination guidance."
Autoimmune Inflammatory Disease Increases Risk of COVID-19 Hospitalization
July 15, 2022
"COVID-19 raises special concerns regarding its course and outcome among patients with IMIDs," investigators stated.
Emotional Stressors May Trigger PFAPA Attacks in Pediatric Patients
July 14, 2022
“These results show that emotional distress is associated with higher frequency of PFAPA attacks, thus may be considered as an environmental trigger for PFAPA attack," investigators stated.
COVID-19 Booster Linked to Lower Infection Rates in Patients with SLE
July 13, 2022
Additional doses improved seroconversion and most vaccinated patients with lupus experienced a generally mild course of the disease.